nitrous oxide has been researched along with Kidney Failure, Chronic in 13 studies
Nitrous Oxide: Nitrogen oxide (N2O). A colorless, odorless gas that is used as an anesthetic and analgesic. High concentrations cause a narcotic effect and may replace oxygen, causing death by asphyxia. It is also used as a food aerosol in the preparation of whipping cream.
dinitrogen oxide : A nitrogen oxide consisting of linear unsymmetrical molecules with formula N2O. While it is the most used gaseous anaesthetic in the world, its major commercial use, due to its solubility under pressure in vegetable fats combined with its non-toxicity in low concentrations, is as an aerosol spray propellant and aerating agent for canisters of 'whipped' cream.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent trials indicate that rapacuronium's pharmacokinetic characteristics are influenced by both renal failure and cirrhosis but the time course of a single bolus dose of 1." | 1.31 | Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion. ( Abengochea, A; Atherton, DP; Brown, R; Dempsey, GA; Fisher, DM; Hunter, JM, 2000) |
| "Nitrous oxide gas was utilized for peritoneal insufflation thus permitting the procedure to be accomplished under local anesthesia." | 1.30 | Videolaparoscopic implantation of long-term peritoneal dialysis catheters. ( Crabtree, JH; Fishman, A, 1999) |
| " The pharmacokinetic parameters derived by compartmental modelling were (normal vs." | 1.28 | The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide. ( Caldwell, JE; Canfell, PC; Castagnoli, KP; Fahey, MR; Fisher, DM; Lynam, DP; Miller, RD, 1989) |
| "2." | 1.28 | Disposition of alfentanil in patients receiving a renal transplant. ( Bower, S; Sear, JW, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coskunfirat, N | 1 |
| Hadimioglu, N | 1 |
| Ertug, Z | 1 |
| Akbas, H | 1 |
| Davran, F | 1 |
| Ozdemir, B | 1 |
| Aktas Samur, A | 1 |
| Arici, G | 1 |
| Driessen, JJ | 1 |
| Robertson, EN | 1 |
| Van Egmond, J | 1 |
| Booij, LH | 1 |
| Takita, K | 1 |
| Goda, Y | 1 |
| Kemmotsu, O | 1 |
| Mashio, H | 1 |
| Okuyama, A | 1 |
| Ito, Y | 1 |
| Sakamoto, H | 1 |
| Kawahigashi, H | 1 |
| Crabtree, JH | 1 |
| Fishman, A | 1 |
| Fisher, DM | 2 |
| Dempsey, GA | 1 |
| Atherton, DP | 1 |
| Brown, R | 1 |
| Abengochea, A | 1 |
| Hunter, JM | 1 |
| Cronnelly, R | 1 |
| Stanski, DR | 1 |
| Miller, RD | 2 |
| Sheiner, LB | 1 |
| Sohn, YJ | 1 |
| Caldwell, JE | 1 |
| Canfell, PC | 1 |
| Castagnoli, KP | 1 |
| Lynam, DP | 1 |
| Fahey, MR | 1 |
| Bower, S | 1 |
| Sear, JW | 1 |
| Estafanous, FG | 1 |
| Porter, JK | 1 |
| el-Tawil, MY | 1 |
| Popowniak, KL | 1 |
| McLaughlin, AP | 1 |
| Altwein, JE | 1 |
| Kessler, WO | 1 |
| Gittes, RF | 1 |
| Hagood, CO | 1 |
| Kemmerer, WT | 1 |
| Jackson, B | 1 |
| Hewitt, PB | 1 |
| Kacki, J | 1 |
| Siedlecki, J | 1 |
| Mayzner, E | 1 |
| Zawadzki, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children With Cochlear Implant Surgery[NCT03595163] | 80 participants (Anticipated) | Interventional | 2018-01-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for nitrous oxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Anaesthesia in irreversible renal failure.
Topics: Anesthesia; Anesthesia, Conduction; Anesthesia, General; Anesthesia, Local; Anesthesia, Spinal; Bloo | 1970 |
1 trial available for nitrous oxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Homocysteine levels after nitrous oxide anesthesia for living-related donor renal transplantation: a randomized, controlled, double-blind study.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Double-Blind Method; Female; Folic Acid; Homocy | 2015 |
11 other studies available for nitrous oxide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Time-course of action of rocuronium 0.3 mg.kg-1 in children with and without endstage renal failure.
Topics: Androstanols; Anesthesia, General; Anesthetics, Inhalation; Case-Control Studies; Child, Preschool; | 2002 |
Secondary hyperparathyroidism shortens the action of vecuronium in patients with chronic renal failure.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Case-Control Studies; Electromyography; Female; Fen | 1995 |
Videolaparoscopic implantation of long-term peritoneal dialysis catheters.
Topics: Adult; Aged; Catheters, Indwelling; Female; Humans; Insufflation; Kidney Failure, Chronic; Laparosco | 1999 |
Effect of renal failure and cirrhosis on the pharmacokinetics and neuromuscular effects of rapacuronium administered by bolus followed by infusion.
Topics: Adolescent; Adult; Age Factors; Aged; Anesthetics, Inhalation; Female; Humans; Kidney Failure, Chron | 2000 |
Renal function and the pharmacokinetics of neostigmine in anesthetized man.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Atropine; Half-Life; Halothane; Humans; Kidney | 1979 |
The influence of renal failure on the pharmacokinetics and duration of action of pipecuronium bromide in patients anesthetized with halothane and nitrous oxide.
Topics: Adult; Androstane-3,17-diol; Androstanols; Anesthesia, Inhalation; Chromatography, Gas; Halothane; H | 1989 |
Disposition of alfentanil in patients receiving a renal transplant.
Topics: Adult; Alfentanil; Anesthesia; Blood Proteins; Enflurane; Female; Humans; Kidney Failure, Chronic; K | 1989 |
Anaesthetic management of anephric patients and patients in renal failure.
Topics: Anesthesia; Arrhythmias, Cardiac; Blood Transfusion; Electrocardiography; Halothane; Humans; Hypoten | 1973 |
Hazards of gallamine administration in patients with renal failure.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Inhalation; Blood Urea Nitrogen; Duodenal Ulcer; Female; G | 1972 |
Nephrotoxicity associated with methoxyflurane (Penthrane) anesthesia. A report of two cases.
Topics: Anesthesia, Inhalation; History, 17th Century; Humans; Kidney; Kidney Failure, Chronic; Methoxyflura | 1973 |
Anesthetic problems in uremic patients.
Topics: Adrenal Insufficiency; Anemia; Anesthesia; Anesthesia, Conduction; Anesthesia, General; Antihyperten | 1971 |